Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.

Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS.

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1439-45. doi: 10.1167/iovs.09-4009. Epub 2009 Nov 5.

2.

Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis.

Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H.

Nat Med. 2009 Jun;15(6):626-32. doi: 10.1038/nm.1975.

PMID:
19483694
3.

Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography.

Jindahra P, Petrie A, Plant GT.

Brain. 2009 Mar;132(Pt 3):628-34. doi: 10.1093/brain/awp001. Epub 2009 Feb 18.

4.

Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.

Shindler KS, Ventura E, Dutt M, Rostami A.

Exp Eye Res. 2008 Sep;87(3):208-13. doi: 10.1016/j.exer.2008.05.017. Epub 2008 Jun 3.

5.

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

Optic Neuritis Study Group.

Arch Neurol. 2008 Jun;65(6):727-32. doi: 10.1001/archneur.65.6.727.

6.

Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton-DAPI approach.

Lei Y, Garrahan N, Hermann B, Becker DL, Hernandez MR, Boulton ME, Morgan JE.

Invest Ophthalmol Vis Sci. 2008 May;49(5):1940-5. doi: 10.1167/iovs.07-0735.

PMID:
18436826
7.

Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions.

Mháille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, FitzGerald U.

J Neuropathol Exp Neurol. 2008 Mar;67(3):200-11. doi: 10.1097/NEN.0b013e318165b239.

8.

Uveitis associated with multiple sclerosis.

Le Scanff J, Sève P, Renoux C, Broussolle C, Confavreux C, Vukusic S.

Mult Scler. 2008 Apr;14(3):415-7. doi: 10.1177/1352458507083444. Epub 2008 Jan 21.

PMID:
18208897
9.

An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography.

Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT, Miller DH.

Brain. 2008 Jan;131(Pt 1):277-87. Epub 2007 Dec 4.

10.

Retinal nerve fibre layer imaging compared with histological measurements in a human eye.

Blumenthal EZ, Parikh RS, Pe'er J, Naik M, Kaliner E, Cohen MJ, Prabakaran S, Kogan M, Thomas R.

Eye (Lond). 2009 Jan;23(1):171-5. Epub 2007 Aug 24.

PMID:
17721504
11.

Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas.

Korsholm K, Madsen KH, Frederiksen JL, Skimminge A, Lund TE.

Brain. 2007 May;130(Pt 5):1244-53.

12.

Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.

Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P.

Neurology. 2007 May 1;68(18):1488-94.

PMID:
17470751
13.

Measuring brain atrophy in multiple sclerosis.

De Stefano N, Battaglini M, Smith SM.

J Neuroimaging. 2007 Apr;17 Suppl 1:10S-15S. Review.

PMID:
17425728
14.

Glaucoma as a neurodegenerative disease.

Gupta N, Yücel YH.

Curr Opin Ophthalmol. 2007 Mar;18(2):110-4. Review.

PMID:
17301611
15.

Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Forooghian F, Sproule M, Westall C, Gordon L, Jirawuthiworavong G, Shimazaki K, O'Connor P.

Doc Ophthalmol. 2006 Sep;113(2):123-32. Epub 2006 Sep 14.

PMID:
16972082
16.

Quantifying axonal loss after optic neuritis with optical coherence tomography.

Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freedman MS, Zackon DH, Kardon RH.

Ann Neurol. 2006 Jun;59(6):963-9.

PMID:
16718705
17.

Clinical practice. Optic neuritis.

Balcer LJ.

N Engl J Med. 2006 Mar 23;354(12):1273-80. Review. No abstract available.

PMID:
16554529
18.

Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.

Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ.

Ophthalmology. 2006 Feb;113(2):324-32. Epub 2006 Jan 10.

PMID:
16406539
19.

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H.

Brain. 2005 Nov;128(Pt 11):2705-12. Epub 2005 Oct 17.

20.

Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.

Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH.

Ann Neurol. 2005 Sep;58(3):383-91.

PMID:
16075460
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk